Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea

Jii Bum Lee, Minkyu Jung, June Hyuk Kim, Bo Hyun Kim, Yeol Kim, Young Seok Kim, Byung Chang Kim, Jin Kim, Sung Ho Moon, Keon Uk Park, Meerim Park, Hyeon Jin Park, Sung Hoon Sim, Hong Man Yoon, Soo Jung Lee, Eunyoung Lee, June Young Chun, Youn Kyung Chung, So Youn Jung, Jinsoo ChungEun Sook Lee, Hyun Cheol Chung, Tak Yun, Sun Young Rha

Research output: Contribution to journalReview articlepeer-review

Abstract

At the end of 2019, the cause of pneumonia outbreaks in Wuhan, China, was identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In February 2020, the World Health Organization named the disease cause by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). In response to the pandemic, the Korean Cancer Association formed the COVID-19 task force to develop practice guidelines. This special article introduces the clinical practice guidelines for cancer patients which will help oncologists best manage cancer patients during the COVID-19 pandemic.

Original languageEnglish
Pages (from-to)323-329
Number of pages7
JournalCancer Research and Treatment
Volume53
Issue number2
DOIs
Publication statusPublished - 2021 Apr

Bibliographical note

Funding Information:
We would like to thank all the board members from the Korean Cancer Association and the Office of Public Relations and Collaboration at the National Cancer Center, South Korea, for supporting the development of these COVID-19 clinical practice guidelines for cancer care.

Publisher Copyright:
Copyright © 2021 by the Korean Cancer Association

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea'. Together they form a unique fingerprint.

Cite this